*The following content is generated by AI and is for reference only.
Overview
Alectinib is a selective ALK inhibitor used in oncology. Its chemical structure is defined by the molecular formula C24H25F3N4O2 and CAS number 1229914-82-6.
Application
- Treatment of ALK-positive non-small cell lung cancer (NSCLC).
- First-line therapy for patients with metastatic disease.
- Management of resistance mutations after crizotinib failure.
Precautions
Strict clinical monitoring required for hepatotoxicity and bradycardia. Store under controlled room temperature in moisture-proof containers to maintain stability.